Cargando…

Effects of Eprosartan on Serum Metabolic Parameters in Patients with Essential Hypertension

The effect of the anti-hypertensive drug eprosartan on metabolic parameters is currently not extensively documented. We evaluated the effect of eprosartan on parameters involved in atherogenesis, oxidative stress and clotting activity. This open-label unblinded intervention study included 40 adult p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rizos, Evangelos C, Spyrou, Athanasia, Liberopoulos, Evangelos N, Papavasiliou, Eleni C, Saougos, Vasilis, Tselepis, Alexandros D, Elisaf, Moses
Formato:	Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers Ltd. 2007
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2570567/ https://www.ncbi.nlm.nih.gov/pubmed/18949087 http://dx.doi.org/10.2174/1874192400701010022

Ejemplares similares

The effect of combining rosuvastatin with sartans of different peroxisome proliferator receptor-γ activating capacity on plasma 8-isoprostane prostaglandin F(2a) levels
por: Rizos, Christos V., et al.
Publicado: (2013)

Effects of increased body weight and short-term weight loss on serum PCSK9 levels – a prospective pilot study
por: Filippatos, Theodosios D, et al.
Publicado: (2017)

LDL cholesterol estimation in patients with the metabolic syndrome
por: Gazi, Irene, et al.
Publicado: (2006)

Vitamin D status and cardiometabolic risk factors in Greek adolescents with obesity – the effect of vitamin D supplementation: a pilot study
por: Makariou, Stefania E., et al.
Publicado: (2020)

No effect of fenugreek, bergamot and olive leaf extract on glucose homeostasis in patients with prediabetes: a randomized double-blind placebo-controlled study
por: Florentin, Matilda, et al.
Publicado: (2019)

Life-threatening hypophosphataemia in a cirrhotic patient with jaundice
por: Moutzouri, Elisavet, et al.
Publicado: (2011)

Electrolyte and acid-base disorders in inflammatory bowel disease
por: Barkas, Fotis, et al.
Publicado: (2013)

Add-on-Statin Extended Release Nicotinic Acid/Laropiprant but Not the Switch to High-Dose Rosuvastatin Lowers Blood Pressure: An Open-Label Randomized Study
por: Kei, Anastazia, et al.
Publicado: (2011)

Attainment of multifactorial treatment targets among the elderly in a lipid clinic
por: Barkas, Fotios, et al.
Publicado: (2015)

Effects of Thyroid Dysfunction on Lipid Profile
por: Rizos, C.V, et al.
Publicado: (2011)

No effect of vitamin D supplementation on cardiovascular risk factors in subjects with metabolic syndrome: a pilot randomised study
por: Makariou, Stefania E., et al.
Publicado: (2017)

Statin escape phenomenon: Fact or fiction?
por: Barkas, Fotios, et al.
Publicado: (2017)

Effects of Eprosartan on Diastolic Function and Neurohormones in Patients with Hypertension and Diastolic Dysfunction
por: Voors, Adriaan A., et al.
Publicado: (2010)

Effects of Eprosartan on Target Organ Protection
por: de la Sierra, Alejandro
Publicado: (2006)

The relationship of vitamin D with non-traditional risk factors for cardiovascular disease in subjects with metabolic syndrome
por: Makariou, Stefania, et al.
Publicado: (2012)

Effect of Plant Polyphenols on Adipokine Secretion from Human SGBS Adipocytes
por: Derdemezis, Christos S., et al.
Publicado: (2011)

Eprosartan mesylate, an angiotensin II receptor antagonist
por: Qian, Jing-Jing, et al.
Publicado: (2011)

Lichenoid drug eruption due to eprosartan/hydrochlorothiacide
por: Ruiz-Villaverde, Ricardo, et al.
Publicado: (2011)

Differences in metabolic parameters and cardiovascular risk between American Diabetes Association and World Health Organization definition of impaired fasting glucose in European Caucasian subjects: a cross-sectional study
por: Filippatos, Theodosios D., et al.
Publicado: (2013)

Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study
por: Athyros, Vassilios G., et al.
Publicado: (2011)

Euglycemic Diabetic Ketoacidosis Secondary to Dapagliflozin in a Patient with Colon Malignancy
por: Papadokostaki, Eleni, et al.
Publicado: (2019)

Reduced Serum Vitamin D Levels Are Associated with Insulin Resistance in Patients with Obstructive Sleep Apnea Syndrome
por: Archontogeorgis, Kostas, et al.
Publicado: (2019)

Clinical Profile of Eprosartan: A Different Angiotensin II Receptor Blocker
por: Blankestijn, P. J, et al.
Publicado: (2008)

Simultaneous analysis of eprosartan and hydrochlorothiazide in tablets by high-performance liquid chromatography
por: Patel, Harsha U., et al.
Publicado: (2011)

Patients with early rheumatoid arthritis exhibit elevated autoantibody titers against mildly oxidized low-density lipoprotein and exhibit decreased activity of the lipoprotein-associated phospholipase A(2)
por: Lourida, Evangelia S, et al.
Publicado: (2007)

Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment – a prospective, controlled study
por: Georgiadis, Athanasios N, et al.
Publicado: (2006)

COVID-19 and diabetes: What does the clinician need to know?
por: Papadokostaki, Eleni, et al.
Publicado: (2020)

Formulation and characterization of novel soft nanovesicles for enhanced transdermal delivery of eprosartan mesylate
por: Ahad, Abdul, et al.
Publicado: (2017)

Attainment of cholesterol target values in Greece: results from the Dyslipidemia International Study II
por: Liberopoulos, Evangelos, et al.
Publicado: (2018)

Editorial: Secondary Dyslipidemias
por: Elisaf, Moses, et al.
Publicado: (2011)

Eprosartan improves cardiac function in swine working heart model of ischemia-reperfusion injury
por: Weymann, Alexander, et al.
Publicado: (2014)

Formulation and characterization of eprosartan mesylate and β-cyclodextrin inclusion complex prepared by microwave technology
por: Ahad, Abdul, et al.
Publicado: (2022)

Severe hyperkalemia following blood transfusions: Is there a link?
por: Rizos, Christos V, et al.
Publicado: (2017)

Eprosartan-based hypertension therapy, systolic arterial blood pressure and cognitive function: analysis of Middle East data from the OSCAR study
por: Radaideh, Ghazi Ahmad, et al.
Publicado: (2011)

Assessing forgetfulness and polypharmacy and their impact on health-related quality of life among patients with hypertension and dyslipidemia in Greece during the COVID-19 pandemic
por: Souliotis, Kyriakos, et al.
Publicado: (2021)

Dyslipidemia Associated with Chronic Kidney Disease
por: Tsimihodimos, Vasilis, et al.
Publicado: (2011)

Development and Validation of a UV Spectrophotometric Method for the Simultaneous Estimation of Eprosartan Mesylate and Hydrochlorothiazide in Bulk and Formulations
por: Anandakumar, K., et al.
Publicado: (2011)

Early Signs of Atherogenic Features in the HDL Lipidomes of Normolipidemic Patients Newly Diagnosed with Type 2 Diabetes
por: Kostara, Christina E., et al.
Publicado: (2020)

Losartan and Eprosartan Induce a Similar Effect on the Acute Rise in Serum Uric Acid Concentration after an Oral Fructose Load in Patients with Metabolic Syndrome
por: Masajtis-Zagajewska, Anna, et al.
Publicado: (2021)

Hypercalcemia and acute renal failure associated with calcium carbonate consumption in a patient with hypoparathyroidism
por: Mitrogianni, Zoi, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_aj3oqeq2du6qas22hbfcrvngtb